Accuracy of dispersing tramadol capsules for oral administration in young children

M Kluger1, S Penrose2, A R Bjorksten3

  • 1Consultant Anaesthetist, Anaesthesia, Royal Melbourne Hospital, Melbourne, Victoria.

Insights

Dispensing tramadol (a pain medication) from 50 mg capsules for children under 12 is a viable alternative to oral drops. This method ensures accurate and safe dosing for pediatric patients.

Area of Science:

  • Pediatric Pharmacology
  • Pain Management
  • Pharmaceutical Compounding

Background:

  • Oral tramadol drops (100 mg/ml) are used for pediatric analgesia, especially post-adenotonsillectomy.
  • The Australian Therapeutic Goods Administration advises against tramadol drops in children under 12 due to overdose risks.
  • A 50 mg tramadol capsule is the only alternative preparation for smaller pediatric doses.

Purpose of the Study:

  • To assess the accuracy and safety of preparing pediatric tramadol doses from 50 mg capsules.
  • To evaluate an alternative method for tramadol administration in children under 12 years.

Main Methods:

  • Twenty surgical ward nurses were tasked with preparing a 15 mg tramadol dose from a 50 mg capsule.
  • The accuracy of the prepared doses was measured against the target 15 mg dose.

Main Results:

  • Doses were within ±5% of 15 mg in 65% of preparations (13/20 nurses).
  • Doses were within ±10% of 15 mg in 95% of preparations (19/20 nurses).
  • The range of prepared doses was 13.9-17.1 mg, considered clinically acceptable and safe.

Conclusions:

  • Preparing tramadol doses by dispersing 50 mg capsules is sufficiently accurate for clinical pediatric use.
  • This method is considered safe, with dose variability unlikely to cause significant toxicity.
  • The maximum dose administered is limited by the capsule strength (50 mg), enhancing safety.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
669
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
622
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
394
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414